StockStory.org on MSN14h
3 Reasons HSIC is Risky and 1 Stock to Buy InsteadHenry Schein has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The ...
The private-equity firm KKR has taken a big stake in the medical- and dental-supply company Henry Schein and plans to work with the company to improve its operations. KKR has amassed a large stake in ...
Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor disclosed a strategic investment of an additional $250 million from funds ...
Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...
former CEO of Henry Schein's Global Dental Group, and A.J. Caffentzis, former president of its U.S. dental division. The departures raised concerns that top executives who might have been ...
BofA analyst Allen Lutz double upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69. The firm believes ...
Henry Schein Inc. closed 8.02% below its 52-week high of $82.63, which the company reached on February 27th.
State of Alaska Department of Revenue lowered its holdings in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 37.5% in the 4th quarter, according to the company in its most recent 13F filing with ...
KKR & Co. has taken a 12% stake in Henry Schein Inc. and will work with the company to improve operations at the world’s largest distributor of medical products to office-based dentists and doctors.
In 2025, nearly 1,100 GKAS events are scheduled to take place throughout the nation, and it is estimated that approximately ...
Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), is paying tribute to women athletic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results